Efficacy of radiofrequency ablation following transarterial chemoembolisation combined with sorafenib for intermediate stage recurrent hepatocellular carcinoma: a retrospective, multicentre, cohort studyResearch in context

Summary: Background: The evidence of radiofrequency ablation (RFA) following transarterial chemoembolisation (TACE) combined with sorafenib for intermediate-stage recurrent hepatocellular carcinoma (RHCC) is limited. Patient responses to this treatment vary because of the heterogeneous nature of RH...

Descrición completa

Detalles Bibliográficos

Principais autores:	Xiao-Hui Wang, Wen-Bin Duan, Wei Liang, Hui Li, Xiao-Yan Xie, Shao-Qiang Li, Min-Shan Chen, Ping Liang, Xian-Hai Mao, Qun-Fang Zhou
Formato:	Artigo
Idioma:	Inglês
Publicado:	Elsevier 2023-02-01
Series:	EClinicalMedicine
Assuntos:	Recurrent hepatocellular carcinoma Intermediate-stage Transarterial chemoembolisation Sorafenib Radiofrequency ablation
Acceso en liña:	http://www.sciencedirect.com/science/article/pii/S2589537022005454
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!